Opinion|Videos|November 30, 2023
Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment
Author(s)Sara M. Tolaney, MD, MPH
Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease to their oncology care team to facilitate early intervention and management of side effects.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer
2
All FDA Oncology Approvals From September 2025
3
Pelvic Physical Therapy After Cancer Restores Intimacy, Wellness
4
September Blood Cancer Updates: What Patients Should Know
5
